LETICIA COOPER: Open Payments
NPI 1841826724 · LUBBOCK, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,348 in 62 payments from 16 companies in 2025. Trend: 2023 $1,398 · 2024 $857 · 2025 $1,348
Food & beverage: $1,348
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 14 | $224 |
| Calliditas Therapeutics US Inc. | 6 | $183 |
| Otsuka America Pharmaceutical, Inc. | 8 | $178 |
| Amgen Inc. | 6 | $161 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 7 | $137 |
| Novo Nordisk Inc | 4 | $100 |
| AstraZeneca Pharmaceuticals LP | 3 | $65 |
| OPKO Pharmaceuticals, LLC | 3 | $58 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $47 |
| ANI Pharmaceuticals, Inc. | 2 | $46 |
Products named: Kerendia, TARPEYO, JYNARQUE, TAVNEOS, JARDIANCE, Ozempic, RAYALDEE, GATTEX.
Industry payments across TX — which companies pay providers there.
